TY - JOUR
T1 - Low intensity focused ultrasound stimulation in stroke
T2 - A phase I safety & feasibility trial
AU - Huang, Ziping
AU - Charalambous, Charalambos C.
AU - Chen, Mengyue
AU - Kim, Taewon
AU - Sokhadze, Estate
AU - Song, Allen
AU - Jung, Sin Ho
AU - Shekhar, Shashank
AU - Feld, Jody A.
AU - Jiang, Xiaoning
AU - Feng, Wuwei
N1 - Publisher Copyright:
© 2025 The Authors
PY - 2025/1/1
Y1 - 2025/1/1
N2 - Objective: We aimed to determine the maximum safe spatial-peak pulse-average intensity (ISPPA) of low-intensity focused ultrasound stimulation (LIFUS) in stroke patients and explore its effect on motor learning and corticospinal excitability. Methods: We adopted the classic 3 + 3 design to escalate ISPPA (estimated in-vivo transcranial value) from 0, 1, 2, 4, 6, to 8 W/cm2. Stopping rules were pre-defined: 2nd-degree scalp burn, clinical seizure, new lesion on diffusion-weighted imaging or major reduction in apparent diffusion coefficient, and participant discontinuation due to any reason. We applied 12-min LIFUS over the ipsilesional motor cortex while participants were concurrently practicing 3 blocks of a motor sequence learning (MSL) task using the affected hand. We measured MSL (response time) and corticospinal excitability (motor evoked potential) pre- and post-stimulation and compared MSL and corticospinal excitability between the LOW (0, 1, and 2 W/cm2) and HIGH (4, 6, and 8 W/cm2) groups. Results: ISPPA was escalated to 8 W/cm2 with 18 stroke participants without meeting the stopping rules. Compared to the LOW, more participants in the HIGH performed better on MSL (6/9 vs. 0/9, p = 0.009) and showed a sign of greater corticospinal excitability (7/9 vs. 5/9, p = 0.62). Interpretation: Our phase-I safety study suggests that one session of LIFUS up to 8 W/cm2 ISPPA is safe and feasible in stroke patients, and LIFUS at high intensity induces positive changes in both MSL and corticospinal excitability. The next logical step is to conduct a phase-II trial testing the efficacy of LIFUS and continuously monitoring its safety profiles.
AB - Objective: We aimed to determine the maximum safe spatial-peak pulse-average intensity (ISPPA) of low-intensity focused ultrasound stimulation (LIFUS) in stroke patients and explore its effect on motor learning and corticospinal excitability. Methods: We adopted the classic 3 + 3 design to escalate ISPPA (estimated in-vivo transcranial value) from 0, 1, 2, 4, 6, to 8 W/cm2. Stopping rules were pre-defined: 2nd-degree scalp burn, clinical seizure, new lesion on diffusion-weighted imaging or major reduction in apparent diffusion coefficient, and participant discontinuation due to any reason. We applied 12-min LIFUS over the ipsilesional motor cortex while participants were concurrently practicing 3 blocks of a motor sequence learning (MSL) task using the affected hand. We measured MSL (response time) and corticospinal excitability (motor evoked potential) pre- and post-stimulation and compared MSL and corticospinal excitability between the LOW (0, 1, and 2 W/cm2) and HIGH (4, 6, and 8 W/cm2) groups. Results: ISPPA was escalated to 8 W/cm2 with 18 stroke participants without meeting the stopping rules. Compared to the LOW, more participants in the HIGH performed better on MSL (6/9 vs. 0/9, p = 0.009) and showed a sign of greater corticospinal excitability (7/9 vs. 5/9, p = 0.62). Interpretation: Our phase-I safety study suggests that one session of LIFUS up to 8 W/cm2 ISPPA is safe and feasible in stroke patients, and LIFUS at high intensity induces positive changes in both MSL and corticospinal excitability. The next logical step is to conduct a phase-II trial testing the efficacy of LIFUS and continuously monitoring its safety profiles.
UR - http://www.scopus.com/inward/record.url?scp=85215843812&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85215843812&partnerID=8YFLogxK
U2 - 10.1016/j.brs.2025.01.015
DO - 10.1016/j.brs.2025.01.015
M3 - Article
C2 - 39842609
AN - SCOPUS:85215843812
SN - 1935-861X
VL - 18
SP - 179
EP - 187
JO - Brain Stimulation
JF - Brain Stimulation
IS - 1
ER -